Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials

M Bohm, M Baumhakel, K Teo, P Sleight, J Probstfield, P Gao, J. F Mann, R Diaz, G. R Dagenais, G. L. R Jennings, L Liu, P Jansky, S Yusuf and for the ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators

Circulation 121 ( 12 ): 1439 - 1446 , 2010